Phenotypic characterization of spatial cognition and social behavior in mice with ‘knockout’ of the schizophrenia risk gene neuregulin 1
暂无分享,去创建一个
J. Waddington | R. Harvey | C. O’Tuathaigh | C.M.P. O’Tuathaigh | D. Babovic | G. J. O’Sullivan | J. J. Clifford | O. Tighe | D. T. Croke | R. Harvey | J. L. Waddington | O. Tighe | D. Croke | J. Clifford | C. O'Tuathaigh | G. O'Sullivan | D. Babovic
[1] J. Buxbaum,et al. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia , 2004, Nature Neuroscience.
[2] D. Clair,et al. Confirmation and refinement of an ‘at-risk’ haplotype for schizophrenia suggests the EST cluster, Hs.97362, as a potential susceptibility gene at the Neuregulin-1 locus , 2004, Molecular Psychiatry.
[3] G. Arendash,et al. Adaptation of the circular platform spatial memory task for mice: use in detecting cognitive impairment in the APPSW transgenic mouse model for Alzheimer’s disease , 1999, Journal of Neuroscience Methods.
[4] R Hashimoto,et al. Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia , 2004, Molecular Psychiatry.
[5] R. Gerlai,et al. Heregulin, but not ErbB2 or ErbB3, heterozygous mutant mice exhibit hyperactivity in multiple behavioral tasks , 2000, Behavioural Brain Research.
[6] G. Fischbach,et al. Differential expression of ARIA isoforms in the rat brain , 1995, Neuron.
[7] Paul J. Harrison,et al. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence , 2005, Molecular Psychiatry.
[8] N. Andreasen. Schizophrenia: the fundamental questions , 2000, Brain Research Reviews.
[9] Paul J. Harrison,et al. Neuregulin-1 (NRG-1) mRNA and protein in the adult human brain , 2004, Neuroscience.
[10] J. Gogos,et al. Modeling Madness in Mice: One Piece at a Time , 2006, Neuron.
[11] J. Loeb,et al. Neuregulins: Versatile growth and differentiation factors in nervous system development and human disease , 2006, Brain Research Reviews.
[12] T. Holy,et al. Loss of sex discrimination and male-male aggression in mice deficient for TRP2. , 2002, Nature Reviews Genetics.
[13] M. Munafo,et al. Association of the NRG1 gene and schizophrenia: a meta-analysis , 2006, Molecular Psychiatry.
[14] K. Seroogy,et al. Supranigral injection of neuregulin1-β induces striatal dopamine overflow , 2004, Brain Research.
[15] C. Salum,et al. The effect of amphetamine on Kamin blocking and overshadowing , 2003, Behavioural pharmacology.
[16] Maria Karayiorgou,et al. Schizophrenia genetics: uncovering positional candidate genes , 2006, European Journal of Human Genetics.
[17] H. Eichenbaum,et al. The perirhinal–entorhinal cortex, but not the hippocampus, is critical for expression of individual recognition in the context of the Coolidge effect , 2003, Neuroscience.
[18] J. Waddington,et al. Susceptibility genes for schizophrenia: Characterisation of mutant mouse models at the level of phenotypic behaviour , 2007, Neuroscience & Biobehavioral Reviews.
[19] M. A. De Luca,et al. Differential Expression of Motivational Stimulus Properties by Dopamine in Nucleus Accumbens Shell versus Core and Prefrontal Cortex , 2002, The Journal of Neuroscience.
[20] Zhen Yan,et al. Regulation of NMDA Receptors by Neuregulin Signaling in Prefrontal Cortex , 2005, The Journal of Neuroscience.
[21] G. Thaker,et al. Advances in schizophrenia , 2001, Nature Medicine.
[22] M. Golub,et al. Behavioral characteristics of a nervous system-specific erbB4 knock-out mouse , 2004, Behavioural Brain Research.
[23] Marc G Caron,et al. Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia , 1999, Cell.
[24] J. Waddington,et al. The neurodevelopmental basis of schizophrenia: clinical clues from cerebro-craniofacial dysmorphogenesis, and the roots of a lifetime trajectory of disease , 1999, Biological Psychiatry.
[25] S. Kapur,et al. From dopamine to salience to psychosis—linking biology, pharmacology and phenomenology of psychosis , 2005, Schizophrenia Research.
[26] D. Hoffman,et al. Neuregulin-1 Reverses Long-Term Potentiation at CA1 Hippocampal Synapses , 2005, The Journal of Neuroscience.
[27] J. Piven,et al. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic‐like behavior in mice , 2004, Genes, brain, and behavior.
[28] C. Vorhees,et al. Effects of prenatal cocaine on Morris and Barnes maze tests of spatial learning and memory in the offspring of C57BL/6J mice. , 2000, Neurotoxicology and teratology.
[29] R. Freedman,et al. Genetics of Chromosome 15q13-q14 in Schizophrenia , 2006, Biological Psychiatry.
[30] D. Grandy,et al. Ethological resolution of behavioral topography and D2‐like vs. D1‐like agonist responses in congenic D4 dopamine receptor “knockouts”: Identification of D4:D1‐like interactions , 2006, Synapse.
[31] J. Addington,et al. The course of cognitive functioning in first episode psychosis: Changes over time and impact on outcome , 2005, Schizophrenia Research.
[32] Lee M. Silver,et al. Social approach–avoidance behavior of inbred mouse strains towards DBA/2 mice , 2004, Brain Research.
[33] D. Sibley,et al. Ethological resolution of behavioural topography and D1‐like versus D2‐like agonist responses in congenic D5 dopamine receptor mutants: Identification of D5:D2‐like interactions , 2005, Synapse.
[34] R. Siegel,et al. Neuregulin induces GABAA receptor β2 subunit expression in cultured rat cerebellar granule neurons by activating multiple signaling pathways , 2004, Journal of neurochemistry.
[35] J. Coyle,et al. NMDA receptor function, neuroplasticity, and the pathophysiology of schizophrenia. , 2004, International review of neurobiology.
[36] B. Galef,et al. Acute anosmia in the rat: a behavioral test of a peripherally-induced olfactory deficit. , 1971, Physiology & behavior.
[37] Johannes Schwarz,et al. Psychosis pathways converge via D2High dopamine receptors , 2006, Synapse.
[38] A. Cools,et al. Distinct kinds of novelty processing differentially increase extracellular dopamine in different brain regions , 2006, The European journal of neuroscience.
[39] Karin E. Borgmann-Winter,et al. Altered neuregulin 1–erbB4 signaling contributes to NMDA> receptor hypofunction in schizophrenia , 2006, Nature Medicine.
[40] E. Kandel,et al. Impairment of spatial but not contextual memory in CaMKII mutant mice with a selective loss of hippocampal ltp in the range of the θ frequency , 1995, Cell.
[41] J. Waddington,et al. Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology–molecular biology interface , 2005, Psychopharmacology.
[42] Robert Freedman,et al. Proof-of-Concept Trial of an α7 Nicotinic Agonist in Schizophrenia , 2006 .
[43] D. Weinberger,et al. Genetic Mouse Models of Schizophrenia: From Hypothesis-Based To Susceptibility Gene-Based Models , 2006, Biological Psychiatry.
[44] G. Fischbach,et al. An acute effect of neuregulin 1 beta to suppress alpha 7-containing nicotinic acetylcholine receptors in hippocampal interneurons. , 2006, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[45] Douglas L Falls,et al. Neuregulins: functions, forms, and signaling strategies. , 2003, Experimental cell research.
[46] A. Arnold,et al. Tissue-specific expression and regulation of sexually dimorphic genes in mice. , 2006, Genome research.
[47] A. Holmes,et al. Behavioral profiles of inbred strains on novel olfactory, spatial and emotional tests for reference memory in mice , 2002, Genes, brain, and behavior.
[48] Tobias M. Fischer,et al. Receptor tyrosine kinase ErbB4 modulates neuroblast migration and placement in the adult forebrain , 2004, Nature Neuroscience.
[49] J. Lieberman,et al. Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function , 2004, Behavioural Brain Research.
[50] G. Kreutzberg,et al. Neuregulin-1 isoforms are differentially expressed in the intact and regenerating adult rat nervous system , 2007, Journal of Molecular Neuroscience.
[51] Kari Stefansson,et al. Multiple novel transcription initiation sites for NRG1. , 2004, Gene.
[52] Paul J. Harrison,et al. Neuregulin 1 and Schizophrenia: Genetics, Gene Expression, and Neurobiology , 2006, Biological Psychiatry.
[53] H. Stefánsson,et al. Neuregulin 1 and susceptibility to schizophrenia. , 2002, American journal of human genetics.
[54] A. Fasolo,et al. Differential expression of neuregulins and their receptors in the olfactory bulb layers of the developing mouse , 2006, Brain Research.
[55] M. Millan. N-Methyl-d-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives , 2005, Psychopharmacology.
[56] R. Freedman,et al. Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. , 2006, Archives of general psychiatry.
[57] G. Corfas,et al. Neuregulin1 downregulates postsynaptic GABAa receptors at the hippocampal inhibitory synapse , 2004, Hippocampus.
[58] Douglas W. Barrett,et al. Neuregulin-1 immunoglobulin-like domain mutant mice: clozapine sensitivity and impaired latent inhibition , 2005, Neuroreport.
[59] A. Malla,et al. First-episode psychosis: psychopathology, quality of life, and functional outcome. , 2005, Schizophrenia bulletin.
[60] Paul J. Harrison,et al. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[61] A. Buonanno,et al. Neuregulin‐2 is developmentally regulated and targeted to dendrites of central neurons , 2004, The Journal of comparative neurology.
[62] G. Fischbach,et al. An Acute Effect of Neuregulin 1β to Suppress α7-Containing Nicotinic Acetylcholine Receptors in Hippocampal Interneurons , 2006, The Journal of Neuroscience.
[63] N. Tatarenko. [Pathophysiology of schizophrenia]. , 1954, Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova.
[64] Philip D. Harvey,et al. Cognition in schizophrenia: impairments, determinants, and functional importance. , 2005, The Psychiatric clinics of North America.
[65] G. Kirov,et al. Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[66] K. Seroogy,et al. Supranigral injection of neuregulin1-beta induces striatal dopamine overflow. , 2004, Brain research.
[67] J. Waddington,et al. Sexually dimorphic changes in the exploratory and habituation profiles of heterozygous neuregulin-1 knockout mice , 2006, Neuroreport.
[68] M J Owen,et al. Schizophrenia: genes at last? , 2005, Trends in genetics : TIG.
[69] A. Blokland,et al. Assessment of spatial learning abilities of mice in a new circular maze , 2003, Physiology & Behavior.
[70] P. M. Wall,et al. Infralimbic kappa opioid and muscarinic M1 receptor interactions in the concurrent modulation of anxiety and memory , 2002, Psychopharmacology.
[71] L. Almasy,et al. A Novel Missense Mutation in the Transmembrane Domain of Neuregulin 1 is Associated with Schizophrenia , 2006, Biological Psychiatry.
[72] Edward S. Brodkin,et al. A Mouse Model System for Genetic Analysis of Sociability: C57BL/6J Versus BALB/cJ Inbred Mouse Strains , 2006, Biological Psychiatry.
[73] Heather C Whalley,et al. A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms , 2006, Nature Neuroscience.
[74] R. Schreiber,et al. AR-R 17779 improves social recognition in rats by activation of nicotinic α7 receptors , 2004, Psychopharmacology.